MABTAS RA 500MG INJ is a Schedule H drug. MABTAS RA 500MG INJ is composed of: RITUXIMAB (500.0 MG)
Tag: medicine for chronic lymphocytic leukemia
MABTAS N 500MG INJ
MABTAS N 500MG INJ is a Schedule H drug. MABTAS N 500MG INJ is composed of: RITUXIMAB (500.0 MG)
MABTAS N 100MG INJ
MABTAS N 100MG INJ is a Schedule H drug. MABTAS N 100MG INJ is composed of: RITUXIMAB (100.0 MG)
MABTAS 500MG INFUSION
MABTAS 500MG INFUSION is a Schedule H drug. MABTAS 500MG INFUSION is composed of: RITUXIMAB (500.0 MG)
MABTAS 10MG INFUSION
MABTAS 10MG INFUSION is a Schedule H drug. MABTAS 10MG INFUSION is composed of: RITUXIMAB (10.0 MG)
MABALL 500MG INJ
MABALL 500MG INJ is a Schedule H drug. MABALL 500MG INJ is composed of: RITUXIMAB (500.0 MG)
MABALL 100MG INJ
MABALL 100MG INJ is a Schedule H drug. MABALL 100MG INJ is composed of: RITUXIMAB (100.0 MG)
LUPIXIMAB 100MG INJ
LUPIXIMAB 100MG INJ is a Schedule H drug. LUPIXIMAB 100MG INJ is composed of: RITUXIMAB (100.0 MG)
IKGDAR 500MG INJ
IKGDAR 500MG INJ is a Schedule H drug. IKGDAR 500MG INJ is composed of: RITUXIMAB (500.0 MG)
IKGDAR 100MG INJ
IKGDAR 100MG INJ is a Schedule H drug. IKGDAR 100MG INJ is composed of: RITUXIMAB (100.0 MG)